ABVC BioPharma and AiBtl BioPharma to Conduct Innovative Clinical Study on Depression in Cancer Patients
ABVC BioPharma and AiBtl BioPharma conduct groundbreaking clinical study on Depression in Cancer Patients, integrating AI-driven solutions to address the significant challenge of depression among cancer patients.
This pioneering study by ABVC BioPharma and AiBtl BioPharma aims to revolutionize the treatment of depression in cancer patients, offering hope for improved quality of life and better treatment outcomes.
